Skip to main content
Download PDF

Correction to: ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer

Clinical Epigenetics volume 14, Article number: 36 (2022) Cite this article

The Original Article was published on 04 December 2019

Correction to: Clinical Epigenetics (2019) 11:184 https://doi.org/10.1186/s13148-019-0785-z

Following the publication of this article, the authors noted that images of SK-BR-3 group in Fig. 9B were misplaced by mistake. The corrected Fig. 9B and corresponding bar graph is now shown in this correction. The authors confirm that the conclusions of this paper are not affected, and sincerely apologize for this error and any inconvenience that may have caused.

Fig. 9
figure 9

Transfected with miR145-5p inhibitor in MDA-MB231 and SK-BR-3 cell partially reversed ZMYND10’s effect on migration and invasion. a Effect of miR145-5p inhibitor transfection on the migration of MDA-MB231 and SK-BR-3 cells. b Effect of miR145-5p inhibitor transfection on the invasion of MDA-MB231 and SK-BR-3 cells. **p < 0.01; ***p < 0.001

Full size image

Author information

Author notes

  1. Yan Wang and Liangying Dan have contributed equally to this work.

Authors and Affiliations

  1. Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

    Yan Wang, Liangying Dan, Qianqian Li, Bianfei Shao, Fang Yu, Sanxiu He, Shaorong Tian, Jin He, Qian Xiao, Xiaoqian He, Yixiao Feng & Tingxiu Xiang

  2. The People’s Hospital of Tongliang District, Chongqing, China

    Liangying Dan

  3. Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong

    Lili Li & Lan Zhong

  4. Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Thomas C. Putti

  5. Molecular Biology and Lung Cancer Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA

    Yong Lin

Authors
  1. Yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liangying Dan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qianqian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lili Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lan Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bianfei Shao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fang Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sanxiu He
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shaorong Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jin He
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Qian Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Thomas C. Putti
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Xiaoqian He
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yixiao Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Yong Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Tingxiu Xiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tingxiu Xiang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Dan, L., Li, Q. et al. Correction to: ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer. Clin Epigenet 14, 36 (2022). https://doi.org/10.1186/s13148-022-01256-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13148-022-01256-0

Clinical Epigenetics

ISSN: 1868-7083

Contact us